Ono Pharma Drug Acquired in $2.4B Deal Wins FDA Approval for Treating Rare Type of Tumor
An Ono Pharma drug for a type of tumor affecting tissues of the joints is now FDA approved, giving the ...
An Ono Pharma drug for a type of tumor affecting tissues of the joints is now FDA approved, giving the ...
Bain Capital, an investment firm that has spread its life sciences bets mainly across companies developing novel new medicines, is ...
Top of the morning to you, and a fine one it is. Clear blue skies and chilly breezes are wafting ...
Leaders throughout the biopharma world and scientific community struggled to process news on Thursday that President-elect Donald Trump has tapped ...
Acadia Pharmaceuticals committed a lot of money for rights to Daybue, which in the biotech’s hands became the first FDA-approved ...
With Donald Trump now poised to become U.S. president for the second time in January, biotech and pharmaceutical leaders are ...
This is Part 5 of “Behind the Counter,” an in-depth video series demystifying the complex world of patents and drug ...
An Astellas Pharma drug designed to address a novel target has landed a highly anticipated FDA approval for a rare ...
Neuroscience drug developer Lundbeck is expanding its scope to epilepsy via the $2.6 billion acquisition of Longboard Pharmaceuticals, a company ...
An experimental GLP-1 obesity drug from Terns Pharmaceuticals led to a 5.5% reduction in body weight in a small study, ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.